From Price Disclosure and Standardization to Utilization Analysis and Reevaluation
Assessing the Impact of Indemnity Insurance Linkages

The Health Insurance Review and Assessment Service (HIRA) announced on July 9 that it will fully implement a "full-cycle management system for non-reimbursed medical services," integrating information management, utilization management, and post-management of non-reimbursed items. This initiative aims to guarantee the public's right to choose medical services while also creating a rational environment for healthcare utilization.


Full-Cycle Management System for Non-Reimbursed Medical Services Launched... Oversight on Overuse of Manual Therapy and More View original image

Until now, non-reimbursed items have been operated based on the autonomy of medical institutions. However, there have been ongoing concerns that excessive price discrepancies in certain items and increased utilization due to indemnity insurance have resulted in a heavier financial burden for the public.


In response, HIRA has decided not to simply treat non-reimbursed items as being outside the scope of health insurance, but rather to establish a management system that enables the public to make reasonable choices based on sufficient information. HIRA plans to continuously analyze usage patterns to identify problematic situations and promote appropriate utilization, while also strengthening post-management by reevaluating effectiveness and adjusting items outside the institutional framework as necessary.


First, in the area of information management, HIRA will enhance the public's right to know and right to choose by publicly disclosing non-reimbursed prices and improving the procedures for prior explanation and consent. Through standardization of non-reimbursed service names, codes, and criteria, HIRA aims to provide a foundation that allows the public to more easily compare and understand non-reimbursed information across different medical institutions.


In the area of utilization management, HIRA will identify non-reimbursed items that require greater oversight and apply institutional management measures. The conversion of "manual therapy" to a managed benefit, which began on July 1, is the first example of non-reimbursed utilization management. For items prone to overuse, HIRA will establish pricing and appropriate use criteria, and also monitor for the so-called "balloon effect," where demand shifts to other similar non-reimbursed services such as extracorporeal shock wave therapy. Starting this month, the newly established "Non-Reimbursed Management System Improvement Task Force (TF)" will analyze the linkage structure between health insurance and indemnity insurance, and systematically review changes in non-reimbursed usage patterns and the effectiveness of management policies.


In the area of post-management, HIRA will strengthen the reevaluation function and reorganize the system to exclude non-reimbursed items that are ineffective or lack proven safety. Through these initiatives, non-reimbursed items will no longer be left solely to the market but will instead be continuously monitored and managed within a system that comprehensively considers both the public's financial burden and medical necessity.



Hong Seung-kwon, President of HIRA, stated, "The goal of non-reimbursed management is not to limit the public's right to choose medical services, but to guarantee necessary care while reducing excessive utilization and unreasonable financial burdens. We will focus our efforts so that reimbursed, selectively reimbursed, managed benefit, and non-reimbursed items can be organically operated within a unified management system, moving beyond micro-level approaches that only manage individual non-reimbursed items toward a macro-level management system that integrates reimbursed and non-reimbursed items at the patient level."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing